CORDERA, RENZO
 Distribuzione geografica
Continente #
EU - Europa 15.523
Totale 15.523
Nazione #
IT - Italia 15.523
Totale 15.523
Città #
Genova 12.694
Rapallo 1.794
Genoa 1.014
Bordighera 21
Totale 15.523
Nome #
IGF1 regulates PKM2 function through Akt phosphorylation 191
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 173
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 165
Effect of two fasting periods of different duration on ghrelin response to a mixed meal. 164
Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of Hexokinase-II 156
IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells. 155
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 153
Biliopancreatic diversion 148
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 147
Caveolin-1 is essential for Metformin inhibitory effect on IGF1 action in non-small cell lung cancer cells 145
Antipeptide antibodies toward the extracellular domain of insulin receptor beta-subunit. 142
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 142
Alexithymia and eating behaviour in severely obese patients. 140
Evaluation of growth hormone administration in patients with chronic heart failure secondary to coronary artery disease 139
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 137
Cys 786 and Cys 776 in the posttranslational processing of the insulin and IGF-I receptors 133
Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. 131
The interplay between diabetes, depression and affective temperaments: A structural equation model 131
Switching from Glargine to Degludec is not associated with an overt change in glucose control in a cohort of patients with type 1 diabetes: a CGM analysis 129
Glucose-targeted therapy for subjects with Type 2 Diabetes Mellitus: "Primum non nocere" 127
Caveolin-1 down-regulation inhibits insulin-like growth factor-I receptor signal transduction in H9C2 rat cardiomyoblasts. 126
Influence of cell age and ketoaminic linkage on rapid glycosylation of hemoglobin in human red cells in vitro. 126
Serum Leptin and Adiponectin Concentration in Type 2 Diabetes Patients in the Short and Long Term Following Biliopancreatic Diversion. 126
Appetite control and gastrointestinal hormonal behavior (CCK, GLP-1, PYY 1–36) following low doses of a whey protein-rich nutraceutic 125
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 125
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 121
Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35 121
Direct modulation of insulin receptor protein tyrosine kinase by vanadate and anti-insulin receptor monoclonal antibodies. 120
Effect of two different glucose concentrations on insulin receptor mRNA levels in human hepatoma HepG2 cells. 120
Toxic thyroid adenoma: absence of DNA mutations of the TSH receptor and Gs alpha 118
Type 2 Diabetes Remission and Control in Overweight and in Mildly Obese Diabetic Patients at Long-Term Follow-Up After Biliopancreatic Diversion 116
Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity 116
IGF-I induced rapid recruitment of integrin β1 to lipid rafts is Caveolin-1 dependent 116
Exploration of the early insulin response by two small successive loads of I.V. glucose in normal and obese subjects. 115
Changes in serum ghrelin concentration following biliopancreatic diversion for obesity. 114
Species specificity of insulin binding and insulin receptor protein tyrosine kinase activity. 113
Short-term liver function after biliopancreatic diversion. 112
Prediction of Diabetes Remission at Long Term Following Biliopancreatic Diversion 112
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 112
Adipose Tissue Composition in Obesity and After Bariatric Surgery 112
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 111
Highlights from "Italian Standards of care for Diabetes Mellitus 2009-2010". 111
The Effects of Biliopancreatic Diversion on Type 2 Diabetes Mellitus in Patients with Mild Obesity (BMI 30-35 kg/m2) and Simple Overweight (BMI 25-30 kg/m 2) A Prospective Controlled Study. 111
Adipokine Pattern After Bariatric Surgery: Beyond the Weight Loss. 111
Comment on Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149 111
I.V. glucose tolerance test: correlation between FFA, glucose and IRI in normal, obese and diabetic subjects. 111
INSULIN ANALOGUES: FEARS, FACTS AND FANTASIES 110
Substrate specificities of insulin and epidermal growth factor receptor kinases. 110
Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion. 109
Insulin and IGF-I phosphorylate eNOS in HUVECs by a caveolin-1 dependent mechanism. 109
Impaired increase of plasma abscisic acid in response to oral glucose load in type 2 diabetes and in gestational diabetes 108
Role of IRS-1 and SHC activation in 3T3-L1 fibroblasts differentiation. 107
Beta-cell function improvement after biliopancreatic diversion in subjects withtype 2 diabetes and morbid obesity. 107
Long-term clinical and functional impact of biliopancreatic diversion on type 2 diabetes in morbidly and non-morbidly obese patients. 107
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 107
Insulin binding on MOLT 4 cells: effect of a sulfonylurea. 106
IGF-I regulates caveolin 1 and IRS1 interaction in caveolae 106
Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments 105
Association between plasma insulin and angiographically documented significant coronary artery disease. 105
Effect of insulin receptor autophosphorylation on insulin receptor binding. 105
Baseline neutrophil-to-lymphocyte ratio is associated with long-term T2D remission after metabolic surgery 105
Data-driven strategies for robust forecast of continuous glucose monitoring time-series 104
Insulin-like growth factor I (IGF I) receptor autophosphorylation and kinase activity. Effect of a human polyclonal antibody (pIgG) 103
Glibenclamide Mimics Metabolic Effects of Metformin in H9c2 Cells 103
Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. 102
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 102
Increased phosphorylation of ribosomal protein S6 following microinjection of insulin receptor-kinase into Xenopus oocytes. 101
Inhibition of insulin and epidermal growth factor (EGF) receptor autophosphorylation by a human polyclonal IgG. 101
Effects of dietary restriction on serum leptin concentration in obese women. 101
From bariatric to metabolic surgery: Looking for a "disease modifier" surgery for type 2 diabetes. 100
Effects of Gastric Bypass on Type 2. Diabetes in Patients with BMI 30 to 35 99
High-molecular weight adiponectin isoforms increase after biliopancreatic diversion in obese subjects. 99
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia 99
Glimepiride activates eNOS with a mechanism Akt but not caveolin-1 dependent 98
Short-term changes in serum leptin concentration following biliopancreatic diversion 98
Regulation of insulin receptor-associated tyrosine kinase by a polyclonal IgG. 98
The human skeletal muscle glycogenin gene: cDNA, tissue expression and chromosomal localization. 98
Glycosylated haemoglobin (A1c) best values for type 2 diabetes in the battlefield much ado about nothing? (apparently) 98
Bariatric or Metabolic Surgery? 98
The plant hormone abscisic acid increases in human plasma after hyperglycemia and stimulates glucose consumption by adipocytes and myoblasts 97
Energy and nitrogen absorption after biliopancreatic diversion 97
IGF-I induces caveolin 1 tyrosine phosphorylation and translocation in the lipid rafts 96
Plasma ghrelin concentratin in the short-term following biliopancreaticdiversion. 96
Pregnancies in an 18-year follow-up after biliopancreatic diversion 96
Regional cerebral blood flow and cerebrovascular reactivity in IDDM. 95
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. 94
high molecular weight adiponectin isoforms increase after bilopancreati diversion in obese subjects 93
Insulin receptor regulation in human mature red cells in vitro. 92
Absence of 619 mutation in the TSH receptor in 7 toxic adenoma 92
Changes in adiponectin and leptin concentrations during glucocorticoid treatment: a pilot study in patients with polymyalgia rheumatica. 92
Substitution of Leu for Pro-193 in the insulin receptor in a patient with a genetic form of severe insulin resistance. 91
Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes. 91
Effects of three low-dose oral contraceptive formulations on lipid metabolism. 90
Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. 90
Porcine and human semisynthetic insulin bind equally to the insulin receptor on red blood cells. 89
HOMA, BMI, and serum leptin levels variations during antiviral treatment suggest virus-related insulin resistance in noncirrhotic, nonobese, and nondiabetic chronic hepatitis C genotype 1 patients 89
Serum levels of osteopontin predict diabetes remission after bariatric surgery 89
Assessing the Actual Clinical Effectiveness of Metabolic/Bariatric Surgery for the Type 2 Diabetes Therapy. 89
Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. 88
CLINICAL STUDY: Acute plasma glucose increase, but not early insulin response, regulates plasma ghrelin. 87
Totale 11.321
Categoria #
all - tutte 38.635
article - articoli 36.188
book - libri 0
conference - conferenze 1.791
curatela - curatele 0
other - altro 194
patent - brevetti 0
selected - selezionate 0
volume - volumi 462
Totale 77.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019801 0 0 0 0 0 0 0 0 0 0 437 364
2019/20204.679 227 123 188 322 422 499 656 325 436 788 499 194
2020/20211.315 97 103 111 112 104 94 88 109 147 141 104 105
2021/20222.156 57 116 126 318 97 181 141 446 102 213 62 297
2022/20232.106 186 135 31 203 387 380 3 195 369 8 182 27
2023/2024724 39 144 14 119 62 145 60 36 62 36 7 0
Totale 15.704